KIAA0494 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.761200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.458000E-01
Normal-vs-Stage2
9.367600E-01
Normal-vs-Stage3
3.292400E-02
Normal-vs-Stage4
2.970400E-01
Stage1-vs-Stage2
6.825600E-01
Stage1-vs-Stage3
8.239500E-02
Stage1-vs-Stage4
1.011550E-01
Stage2-vs-Stage3
6.613800E-02
Stage2-vs-Stage4
5.835900E-02
Stage3-vs-Stage4
3.014200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.009800E-01
Normal-vs-AfricanAmerican
8.397600E-01
Normal-vs-Asian
8.921400E-01
Caucasian-vs-AfricanAmerican
4.604400E-01
Caucasian-vs-Asian
5.800800E-01
AfricanAmerican-vs-Asian
9.679000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.815400E-01
Normal-vs-Female
8.559800E-01
Male-vs-Female
9.209000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.462000E-01
Normal-vs-Age(41-60Yrs)
7.052200E-01
Normal-vs-Age(61-80Yrs)
6.722400E-01
Normal-vs-Age(81-100Yrs)
2.930400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.570000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.333000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.007600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.555400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.191600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.911800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.802600E-01
Normal-vs-Daily Drinker
6.608800E-01
Normal-vs-Weekly Drinker
5.555600E-01
Normal-vs-Occasional Drinker
6.396000E-01
Normal-vs-Social Drinker
8.467200E-01
Non Drinker-vs-Daily Drinker
9.725400E-01
Non Drinker-vs-Weekly Drinker
8.973600E-01
Non Drinker-vs-Occasional Drinker
4.380100E-02
Non Drinker-vs-Social Drinker
4.616000E-01
Daily Drinker-vs-Weekly Drinker
8.925000E-01
Daily Drinker-vs-Occasional Drinker
9.214400E-02
Daily Drinker-vs-Social Drinker
5.578400E-01
Weekly Drinker-vs-Occasional Drinker
9.014400E-02
Weekly Drinker-vs-Social Drinker
4.518600E-01
Occasional Drinker-vs-Social Drinker
2.400200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.254630E-01
Normal-vs-Grade 2
3.250400E-02
Normal-vs-Grade 3
1.546360E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.777400E-03
Grade 1-vs-Grade 3
6.207700E-02
Grade 1-vs-Grade 4
1.254630E-01
Grade 2-vs-Grade 3
1.815810E-01
Grade 2-vs-Grade 4
3.250400E-02
Grade 3-vs-Grade 4
1.546360E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.184600E-01
Normal-vs-NonDiabetic
8.188200E-01
Diabetic-vs-NonDiabetic
4.675600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.362800E-01
Normal-vs-NoPancreatitis
8.181800E-01
Pancreatitis-vs-NoPancreatitis
8.912000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.847400E-01
Normal-vs-N1
9.092000E-01
N0-vs-N1
5.996200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.991400E-01
Normal-vs-TP53-NonMutant
9.806400E-01
TP53-Mutant-vs-TP53-NonMutant
1.586990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
